4//SEC Filing
Kayitalire Louis 4
Accession 0001209191-21-045957
CIK 0001566373other
Filed
Jul 6, 8:00 PM ET
Accepted
Jul 7, 9:13 PM ET
Size
5.0 KB
Accession
0001209191-21-045957
Insider Transaction Report
Form 4
Kayitalire Louis
Chief Medical Officer
Transactions
- Sale
Common Stock
2021-07-02$8.43/sh−1,054$8,885→ 54,383 total
Footnotes (2)
- [F1]Shares sold pursuant to the 10b5-1 Plan entered into by the Reporting Person.
- [F2]Includes 48,828 restricted stock units.
Documents
Issuer
F-star Therapeutics, Inc.
CIK 0001566373
Entity typeother
Related Parties
1- filerCIK 0001831519
Filing Metadata
- Form type
- 4
- Filed
- Jul 6, 8:00 PM ET
- Accepted
- Jul 7, 9:13 PM ET
- Size
- 5.0 KB